NUVATION BIO INC(NYSE:NUVB) stock News

NUVB Latest News, Press Relases and Analysis

All

Press Releases

19 days ago - By: Yahoo Finance - Mentions: GS NUVL

JMP Maintains “Market Outperform” on Nuvation (NUVB) for IBTROZI Launch Plans

24 days ago - By: Nuvation Bio

Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (IBTROZI™) as Preferred Option to Clinical Practice Guidelines in Oncology for Advanced ROS1+ Non-Small Cell Lung Cancers

2 months ago - By: Benzinga - Mentions: XPER EMR BLZE ERII ...

Earnings Scheduled For May 7, 2025

a month ago - By: Yahoo Finance - Mentions: TSLA OVID

Are These 2 'Strong Buy' Rated Growth Stocks Buys Right Now?

a month ago - By: Yahoo Finance - Mentions: PFE REGN BX SUNN ...

US pharma bets big on China to snap up potential blockbuster drugs

a month ago - By: Benzinga

Nuvation Bio's Ibtrozi For ROS1-Positive Lung Cancer Wins FDA Approval

a month ago - By: Nuvation Bio

U.S. Food and Drug Administration Approves Nuvation Bio’s IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer

2 months ago - By: Nuvation Bio Inc.

Nuvation Bio To Present New Data from Pivotal Clinical Studies of Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2025 Annual Meeting

2 months ago - By: Nuvation Bio Inc.

Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Entrectinib at ISPOR 2025

2 months ago - By: Nuvation Bio Inc.

Nuvation Bio to Participate in Upcoming Investor Conferences

2 months ago - By: Yahoo Finance - Mentions: JNJ MDT WGRX LLY ...

Is Johnson & Johnson (JNJ) the Best Medical Device Stock to Buy Now?

2 months ago - By: Yahoo Finance - Mentions: ABT WGRX LLY NVDA ...

Why Abbott Laboratories (ABT) is Among the Best Medical Device Stocks to Buy Now

2 months ago - By: Yahoo Finance - Mentions: NCLH ESI CTLP BMRN ...

Norwegian Cruise Line Holdings Ltd. (NCLH): Among Billionaire Quants’ Two Sigma’s Stock Picks with Huge Upside Potential

2 months ago - By: Yahoo Finance - Mentions: ESI CTLP AMZN MQ ...

Element Solutions Inc (ESI): Among Billionaire Larry Robbins’ Stock Picks with Huge Upside Potential

2 months ago - By: Yahoo Finance - Mentions: GOOG TYL AAPL MSFT ...

Alphabet Inc. (GOOGL): Among Billionaire Quants’ Two Sigma’s 10 Stock Picks with Huge Upside Potential

2 months ago - By: Zacks Investment Research - Mentions: KMDA

Nuvation Bio Inc. (NUVB) Reports Q1 Loss, Tops Revenue Estimates

2 months ago - By: Nuvation Bio Inc.

Nuvation Bio Reports First Quarter 2025 Financial Results and Provides Business Update

3 months ago - By: Nuvation Bio Inc.

Nuvation Bio to Present at The Citizens Life Sciences Conference

3 months ago - By: Nuvation Bio Inc.

Nuvation Bio to Report Results for First Quarter 2025 and Provide Business Update on May 7, 2025

3 months ago - By: Yahoo Finance

Is Nuvation Bio Inc. (NYSE:NUVB) the Best Biotech Penny Stock to Buy According to Hedge Funds?

3 months ago - By: Yahoo Finance - Mentions: GERN GOSS CAN GILD ...

Is Geron Corp. (NASDAQ:GERN) the Best Biotech Penny Stock to Buy According to Hedge Funds?

3 months ago - By: Yahoo Finance - Mentions: GOSS ALSN CAN BTU ...

Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1?

3 months ago - By: Yahoo Finance - Mentions: GLRE GOOG AAPL

Is Nuvation Bio Inc. (NUVB) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?

3 months ago - By: Yahoo Finance - Mentions: IOVA DAWN ARVN VIR ...

Iovance Biotherapeutics, Inc. (IOVA): Among Stocks Under $10 that Will Triple

3 months ago - By: Yahoo Finance - Mentions: RLAY KIND GOSS DAWN ...

Relay Therapeutics, Inc. (RLAY): Among Stocks Under $10 that Will Triple

3 months ago - By: Yahoo Finance - Mentions: GOSS PRLD DAWN VIR ...

Gossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will Triple

3 months ago - By: Yahoo Finance - Mentions: RLAY TSLA DAWN VIR ...

Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple

3 months ago - By: Yahoo Finance - Mentions: ARVN DAWN WMT VIR ...

Arvinas, Inc. (ARVN): Among Stocks Under $10 that Will Triple

3 months ago - By: Yahoo Finance - Mentions: NTLA GOSS IBRX VSAT ...

Intellia Therapeutics, Inc. (NTLA): Among Stocks Under $10 that Will Triple

3 months ago - By: Yahoo Finance - Mentions: LUNR ALHC PBI OPCH ...

Should You Buy Intuitive Machines Stock While It's Trading Below $8?

3 months ago - By: Yahoo Finance - Mentions: ALHC TDOC VG LEGN ...

Why Alignment Healthcare Inc. (ALHC) Surged On Tuesday?

4 months ago - By: Nuvation Bio Inc.

Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference

4 months ago - By: Nuvation Bio Inc.

Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025

4 months ago - By: Nuvation Bio Inc.

Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025

4 months ago - By: Nuvation Bio Inc.

Nuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

5 months ago - By: Nuvation Bio Inc.

NUVATION BIO INC (NUVB) Stock News

NUVB Latest News, Press Relases and Analysis

JMP Maintains “Market Outperform” on Nuvation (NUVB) for IBTROZI Launch Plans

Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib (IBTROZI™) as Preferred Option to Clinical Practice Guidelines in Oncology for Advanced ROS1+ Non-Small Cell Lung Cancers

Earnings Scheduled For May 7, 2025

Are These 2 'Strong Buy' Rated Growth Stocks Buys Right Now?

US pharma bets big on China to snap up potential blockbuster drugs

Nuvation Bio's Ibtrozi For ROS1-Positive Lung Cancer Wins FDA Approval

U.S. Food and Drug Administration Approves Nuvation Bio’s IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer

Nuvation Bio To Present New Data from Pivotal Clinical Studies of Taletrectinib in Advanced ROS1-Positive Non-Small Cell Lung Cancer at ASCO 2025 Annual Meeting

Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Entrectinib at ISPOR 2025

Nuvation Bio to Participate in Upcoming Investor Conferences

Is Johnson & Johnson (JNJ) the Best Medical Device Stock to Buy Now?

Why Abbott Laboratories (ABT) is Among the Best Medical Device Stocks to Buy Now

Norwegian Cruise Line Holdings Ltd. (NCLH): Among Billionaire Quants’ Two Sigma’s Stock Picks with Huge Upside Potential

Element Solutions Inc (ESI): Among Billionaire Larry Robbins’ Stock Picks with Huge Upside Potential

Alphabet Inc. (GOOGL): Among Billionaire Quants’ Two Sigma’s 10 Stock Picks with Huge Upside Potential

Nuvation Bio Inc. (NUVB) Reports Q1 Loss, Tops Revenue Estimates

Nuvation Bio Reports First Quarter 2025 Financial Results and Provides Business Update

Nuvation Bio to Present at The Citizens Life Sciences Conference

Nuvation Bio to Report Results for First Quarter 2025 and Provide Business Update on May 7, 2025

Is Nuvation Bio Inc. (NYSE:NUVB) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Is Geron Corp. (NASDAQ:GERN) the Best Biotech Penny Stock to Buy According to Hedge Funds?

Is Gossamer Bio Inc. (NASDAQ:GOSS) the Best Penny Stock to Invest in Under $1?

Is Nuvation Bio Inc. (NUVB) the Top Healthcare Stock to Buy According to Billionaire David Einhorn?

Iovance Biotherapeutics, Inc. (IOVA): Among Stocks Under $10 that Will Triple

Relay Therapeutics, Inc. (RLAY): Among Stocks Under $10 that Will Triple

Gossamer Bio, Inc. (GOSS): Among Stocks Under $10 that Will Triple

Nuvation Bio Inc. (NUVB): Among Stocks Under $10 that Will Triple

Arvinas, Inc. (ARVN): Among Stocks Under $10 that Will Triple

Intellia Therapeutics, Inc. (NTLA): Among Stocks Under $10 that Will Triple

Should You Buy Intuitive Machines Stock While It's Trading Below $8?

Why Alignment Healthcare Inc. (ALHC) Surged On Tuesday?

Nuvation Bio to Present at the Jones Healthcare and Technology Innovation Conference

Nuvation Bio to Present New Nonclinical Data for Taletrectinib at the American Association for Cancer Research Annual Meeting 2025

Nuvation Bio to Present Matching-adjusted Indirect Comparison Data for Taletrectinib vs. Crizotinib During Mini Oral Presentation at the European Lung Cancer Congress 2025

Nuvation Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Nuvation Bio Secures Up to $250 Million in Non-Dilutive Financings from Sagard Healthcare Partners